259 related articles for article (PubMed ID: 9655399)
21. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
Lam K; Rao VS; Qasba PK
J Biomol Struct Dyn; 1998 Jun; 15(6):1009-27. PubMed ID: 9669548
[TBL] [Abstract][Full Text] [Related]
22. Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity.
Yoneda A; Asada M; Oda Y; Suzuki M; Imamura T
Nat Biotechnol; 2000 Jun; 18(6):641-4. PubMed ID: 10835602
[TBL] [Abstract][Full Text] [Related]
23. The glycine box: a determinant of specificity for fibroblast growth factor.
Luo Y; Lu W; Mohamedali KA; Jang JH; Jones RB; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1998 Nov; 37(47):16506-15. PubMed ID: 9843417
[TBL] [Abstract][Full Text] [Related]
24. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
Aviezer D; Safran M; Yayon A
Biochem Biophys Res Commun; 1999 Oct; 263(3):621-6. PubMed ID: 10512728
[TBL] [Abstract][Full Text] [Related]
25. Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor. FGF-1 recognizes both the (1)C(4) and (2)S(O) conformations of a bioactive heparin-like hexasaccharide.
Canales A; Angulo J; Ojeda R; Bruix M; Fayos R; Lozano R; Giménez-Gallego G; Martín-Lomas M; Nieto PM; Jiménez-Barbero J
J Am Chem Soc; 2005 Apr; 127(16):5778-9. PubMed ID: 15839662
[TBL] [Abstract][Full Text] [Related]
26. An atomic resolution structure for human fibroblast growth factor 1.
Bernett MJ; Somasundaram T; Blaber M
Proteins; 2004 Nov; 57(3):626-34. PubMed ID: 15382229
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
[TBL] [Abstract][Full Text] [Related]
28. S100A13-C2A binary complex structure-a key component in the acidic fibroblast growth factor for the non-classical pathway.
Mohan SK; Rani SG; Kumar SM; Yu C
Biochem Biophys Res Commun; 2009 Mar; 380(3):514-9. PubMed ID: 19284995
[TBL] [Abstract][Full Text] [Related]
29. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor.
Berman B; Ostrovsky O; Shlissel M; Lang T; Regan D; Vlodavsky I; Ishai-Michaeli R; Ron D
J Biol Chem; 1999 Dec; 274(51):36132-8. PubMed ID: 10593896
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factors share binding sites in heparan sulphate.
Kreuger J; Jemth P; Sanders-Lindberg E; Eliahu L; Ron D; Basilico C; Salmivirta M; Lindahl U
Biochem J; 2005 Jul; 389(Pt 1):145-50. PubMed ID: 15769253
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides.
Liu L; Bytheway I; Karoli T; Fairweather JK; Cochran S; Li C; Ferro V
Bioorg Med Chem Lett; 2008 Jan; 18(1):344-9. PubMed ID: 17981035
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog.
Pineda-Lucena A; Jiménez MA; Lozano RM; Nieto JL; Santoro J; Rico M; Giménez-Gallego G
J Mol Biol; 1996 Nov; 264(1):162-78. PubMed ID: 8950275
[TBL] [Abstract][Full Text] [Related]
33. Structural specificity of heparin binding in the fibroblast growth factor family of proteins.
Raman R; Venkataraman G; Ernst S; Sasisekharan V; Sasisekharan R
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2357-62. PubMed ID: 12604799
[TBL] [Abstract][Full Text] [Related]
34. Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide.
Ogura K; Nagata K; Hatanaka H; Habuchi H; Kimata K; Tate S; Ravera MW; Jaye M; Schlessinger J; Inagaki F
J Biomol NMR; 1999 Jan; 13(1):11-24. PubMed ID: 10070748
[TBL] [Abstract][Full Text] [Related]
35. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.
Spivak-Kroizman T; Lemmon MA; Dikic I; Ladbury JE; Pinchasi D; Huang J; Jaye M; Crumley G; Schlessinger J; Lax I
Cell; 1994 Dec; 79(6):1015-24. PubMed ID: 7528103
[TBL] [Abstract][Full Text] [Related]
36. Site-directed mutagenesis and molecular modeling identify a crucial amino acid in specifying the heparin affinity of FGF-1.
Patrie KM; Botelho MJ; Franklin K; Chiu IM
Biochemistry; 1999 Jul; 38(29):9264-72. PubMed ID: 10413500
[TBL] [Abstract][Full Text] [Related]
37. Efficient and inexpensive method for purification of heparin binding proteins.
Batra S; Sahi N; Mikulcik K; Shockley H; Turner C; Laux Z; Badwaik VD; Conte E; Rajalingam D
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2437-42. PubMed ID: 21783437
[TBL] [Abstract][Full Text] [Related]
38. Physical stabilization of acidic fibroblast growth factor by polyanions.
Volkin DB; Tsai PK; Dabora JM; Gress JO; Burke CJ; Linhardt RJ; Middaugh CR
Arch Biochem Biophys; 1993 Jan; 300(1):30-41. PubMed ID: 7678726
[TBL] [Abstract][Full Text] [Related]
39. A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding.
Huhtala MT; Pentikäinen OT; Johnson MS
Structure; 1999 Jun; 7(6):699-709. PubMed ID: 10404599
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans.
Venkataraman G; Shriver Z; Davis JC; Sasisekharan R
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1892-7. PubMed ID: 10051565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
